HenryFungMDFACP, FRCPE
Hematology • Philadelphia, PAHematologic Oncology
Chair and Professor, Department of Bone Marrow Transplant and cellular therapy; Director, Fox Chase - Temple University Hospital BMT Program
Dr. Fung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Ave
Bone Marrow Transplant Service
Philadelphia, PA 19111Phone+1 215-214-3130Fax+1 215-214-3127
Summary
- Dr. Henry Fung is a hematologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Fox Chase Cancer Center-American Oncologic Hospital, Jeanes Hospital, and Temple University Hospital. He received his medical degree from Chinese University of Hong Kong and has been in practice 30 years. He also speaks multiple languages, including Chinese (Cantonese) and Chinese (Mandarin). He specializes in hematologic oncology and is experienced in non-hodgkin lymphoma, hematologic oncology, pure red cell aplasia, hematopoietic stem cell transplantation, and acute myeloid leukemia.
Education & Training
University of Hong Kong Faculty of MedicineClass of 1987, MBchB
Certifications & Licensure
PA State Medical License 2013 - 2024
CA State Medical License 1996 - 2019
IL State Medical License 2005 - 2017- Royal Colleges of Physicians (United Kingdom)Internal Medicine
Awards, Honors, & Recognition
- American Top Doctor (Cancer & Hematology) Castle Connolly Medical, 2014-2022
- Top Doctor (Philadelphia) Philadelphia Magazine, 2018-2021
- FRCPE Royal College of Physician Edinburgh, 2001
- Join now to see all
Clinical Trials
- Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome Start of enrollment: 1999 Jan 01
- Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 946 citationsKTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell LymphomaMichael Wang, Javier Munoz, Andre Goy, Frederick L. Locke, Caron A. Jacobson
The New England Journal of Medicine. 2020-04-01 - 163 citationsPembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trialSaad Z. Usmani, Fredrik Schjesvold, Albert Oriol, Lionel Karlin, Michele Cavo
The Lancet. Haematology. 2019-09-01 - 17 citationsGenomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemiaWoonbok Chung, Andrew Kelly, Patricia Kropf, Henry C. Fung, Jaroslav Jelinek
Clinical Epigenetics. 2019-07-22
Professional Memberships
- Member
- Member
- Fellow
- American Society for Blood and Marrow TransplantationMember
- Royal College of Physician EdinburghFellow
Other Languages
- Chinese (Cantonese), Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
